The past few days now have been a very volatile time for shareholders of Cryoport (NASDAQ:CYRX). Back on March 24th, the stock skyrocketed 24.8% after news broke that Dan Leonard, an analyst at ...

UBS upgraded Cryoport (CYRX) to Buy from Neutral with a $10 price target UBS believes that scaling cell and gene therapy service offerings provide a credible pathway to low-double-digit-plus mid ...

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T ...

CryoPort, Inc. (CYRX) shares ended the last trading session 5.9% higher at $7.04. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

09:30 EST CryoPort (CYRX) trading halted, volatility trading pause See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investm ...

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of MVE Biological Solutions' ("MVE") High ...

As of March 20, 2025, the average one-year price target for Cryoport is $11.50/share. The forecasts range from a low of $6.56 to a high of $15.75. The average price target represents an increase ...

In this article, we are going to take a look at where Cryoport, Inc. (NASDAQ:CYRX) stands against the pump and dump stocks. Pump and dump stocks are typically characterized by high 52-week ...